On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Histiocytic Disorders and Treatments

TopicLeading institutions, researchers & key papers

Histiocytic Disorders and Treatments is a topic indexed in ScholarIQ from OpenAlex.

What is known about Histiocytic Disorders and Treatments?

ScholarIQrecord summary

This cluster of papers focuses on the classification, diagnosis, and treatment of histiocytic disorders, including Langerhans Cell Histiocytosis and Erdheim-Chester Disease. It explores the role of BRAF mutations, immunohistochemical approaches to classification, and consensus guidelines for clinical management. The papers also delve into the pathogenesis, molecular characterization, and therapy intensification for multisystem involvement.

How many works does Histiocytic Disorders and Treatments have?

ScholarIQindexed works

Histiocytic Disorders and Treatments has 70 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Histiocytic Disorders and Treatments?

ScholarIQopenalex

The OpenAlex for Histiocytic Disorders and Treatments is on the source record.

What are the most-cited papers on Histiocytic Disorders and Treatments?

ScholarIQmost cited works
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Jean‐François Emile, Oussama Abla, Sylvie Fraitag, AnnaCarin Horne, Julien Haroche, Jean Donadieu, Luis Requena‐Caballero, Michael B. Jordan, Omar Abdel‐Wahab, Carl E. Allen, Frédéric Charlotte, Eli L. Diamond, R. Maarten Egeler, Alain Fischer, Juana Gil Herrera, Jan‐Inge Henter, Filip Jankú, Miriam Mérad, Jennifer Picarsic, Carlos Rodríguez‐Galindo, Barret J. Rollins, Abdellatif Tazi, Robert Vassallo, Lawrence M. Weiss
Blood. 20161,582 CitationsOPEN ACCESS
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Julien Haroche, Frédéric Charlotte, Laurent Arnaud, Andreas von Deimling, Zofia Hélias‐Rodzewicz, B. Hervier, Fleur Cohen‐Aubart, David Launay, Annette Lesot, Karima Mokhtari, Danielle Canioni, Louise Galmiche, Christian Rosé, Marc Schmalzing, Sandra Croockewit, Marianne Kambouchner, Marie-Christine Copin, Sylvie Fraitag, Felix Sahm, Nicole Brousse, Zahir Amoura, Jean Donadieu, Jean‐François Emile
Blood. 2012694 Citations
Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
Riccardo Haupt, Milen Minkov, Itziar Astigarraga, Eva Schäfer, Vasanta Nanduri, Rima Jubran, R. Maarten Egeler, Gritta Janka, Dragan Mićić, Carlos Rodríguez‐Galindo, Stefaan Van Gool, Johannes Visser, Sheila Weitzman, Jean Donadieu, for the Euro Histio Network
Pediatric Blood & Cancer. 2012693 CitationsOPEN ACCESS
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric D. Jacobsen, Jennifer Picarsic, Zdenka Křenová, Ronald Jaffe, Jean‐François Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen‐Aubart, Carlos Rodríguez‐Galindo, Carl E. Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond
Blood. 2018634 CitationsOPEN ACCESS
Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in Adults
Robert Vassallo, Jay H. Ryu, Darrell R. Schroeder, Paul A. Decker, Andrew H. Limper
New England Journal of Medicine. 2002450 CitationsOPEN ACCESS

Where is Histiocytic Disorders and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Histiocytic Disorders and Treatments is open access?

ScholarIQopen access share
53%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
7%
Bronze
33%
Closed
47%

Related on ScholarIQ

470M+ articles · 14-day free trial